Unleash the power of adult stem cells

Never before has there been such an incredible rate of progress in science and medicine with the promise to improve health. Adult stem cells have the potential to rescue tissues and organs that have been injured from disease. But, this life-giving and life-enhancing gift from our own bodies is being needlessly delayed. Minimal education efforts and public policy debates focused upon embryonic stem cells has led many to assume that all stem cell research is limited to the ethically troubling use of stem cells from embryos. To unleash the healing power of adult stem cell treatments, we’ve created the Cell Therapy Foundation with a three-fold mission to:  foster healthy public awareness, increase research funding and improve collaboration among leading adult stem cell researchers.

 

Mission

The mission of the Cell Therapy Foundation is to improve public health through the support of effective adult stem cell research and education by advancing basic and applied knowledge, processes and therapies.

Vision

The Cell Therapy Foundation will be a premier source for the advancement of adult stem cell awareness, acceleration and development of useful research and therapies which will result in the global improvement of public health.

 
Get Involved

Don’t let adult stem cell research become idle and delay the potential to improve lives around the world. To learn more contact:  Ann Myers, Director of Operations, Cell Therapy Foundation, (317) 459-0170.

Newsletter Sign Up
Contact Form
Research Network

The Web-based Adult Stem Cell Research (ASCR) Network exists to encourage and support global collaboration among adult stem cell scientists and match patients with clinical trials. Worldwide membership includes laboratories in Brazil, France, The Netherlands, Singapore, South Korea, Sweden, Taiwan, and USA.

Visit www.ascrnetwork.org

Success Stories

“I hope that someday when I see an older person having trouble with their leg(s), faced with the same problem I had, they have this revolutionary therapy available for them because of the chance I took as a clinical trial patient.”
Jacque Pentell